Featured Editorial
-
What Happens When The Clinical Forecast Changes?
10/2/2026
A clinical supply forecast is never static. Learn how to turn changing demand, constrained supply, and uncertainty into decisions that protect inventory and study continuity.
-
The Patient Is In The Room. Who Is Dispensing The IP?
10/1/2026
Receiving IP is only the beginning. Explore how the first patient visit can expose gaps in dispensing, delegation, IRT, documentation, and site readiness.
-
When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics
10/1/2026
Radiopharmaceuticals turn time into a supply-chain constraint. Short half-lives, patient scheduling, scarce radionuclides and regulatory differences reshape trial logistics.
-
AI Is Moving Clinical Supply From Forecasting To Real-Time Decision-Making
9/30/2026
AI can do more than improve clinical supply forecasts. By connecting real-time signals, data, and human expertise, it can help teams spot risks sooner and act.
-
One IP Receipt Problem Is An Exception. Four Is A Process.
9/30/2026
Repeated IP receipt problems can reveal a site readiness gap. Learn how recurring CRA intervention can expose fragile processes that need to work without rescue.
-
Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
9/29/2026
This fourth installment of our Root Causes video series examines why even the most well-planned clinical trials often push supply and operations into firefighting mode.
-
Your IP Shipment Arrives At 07:00. Who Opens The Box?
9/29/2026
A shipment can arrive on time and within temperature while a site is still unready. See how small handoff gaps can disrupt IP receipt, storage, and accountability.
-
Segregation Of Duties: Drug Accountability Needs Three Separate Roles
9/28/2026
When one person orders, receives, and reconciles investigational product, a critical control disappears. See how role separation can strengthen drug accountability.
-
When Clinical Demand Becomes A Supply Plan
9/25/2026
Clinical supply planning starts with assumptions, not sales history. See how enrollment, SKUs, approvals, shelf life, yield, inventory, and CDMOs shape the plan.
-
Before The Excursion: The Governance Decisions That Should Already Be Made
9/24/2026
Temperature excursions are inevitable. The real risk is the time lost deciding what to do. See how preplanned governance can turn long quarantines into routine events.